Evidence map›Paper›PMID 29702993›Full record

ArticleMedicine2018

STARD-rapid screening for the 6 most common G6PD gene mutations in the Chinese population using the amplification refractory mutation system combined with melting curve analysis.

Zuqian Fan, Xunjin Weng, Guosheng Huang, Zhijian Pan, Zhao Long, Qiongying Fan, Weijun Tang, Lin Fang, Ju Long, Tian Hu and 2 more

Open access · goldAbstract read
In one paragraph

Article in Medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Zuqian FanDepartment of Clinical Laboratory, Qinzhou Maternal and Child Health Hospital.
Xunjin WengQinzhou Key Laboratory of Molecular and Cell Biology on Endemic Diseases, Qinzhou.
Guosheng HuangQinzhou Key Laboratory of Molecular and Cell Biology on Endemic Diseases, Qinzhou.
Zhijian PanQinzhou Key Laboratory of Molecular and Cell Biology on Endemic Diseases, Qinzhou.
Zhao LongQinzhou Key Laboratory of Molecular and Cell Biology on Endemic Diseases, Qinzhou.
Qiongying FanQinzhou Key Laboratory of Molecular and Cell Biology on Endemic Diseases, Qinzhou.
Weijun TangQinzhou Key Laboratory of Molecular and Cell Biology on Endemic Diseases, Qinzhou.
Lin FangDepartment of Clinical Laboratory, Qinzhou Maternal and Child Health Hospital.
Ju LongQinzhou Key Laboratory of Molecular and Cell Biology on Endemic Diseases, Qinzhou.
Tian HuDepartment of Clinical Laboratory, Qinzhou Maternal and Child Health Hospital.
Yongxia HuangDepartment of Clinical Laboratory, Qinzhou Maternal and Child Health Hospital.
Lei SunQinzhou Key Laboratory of Molecular and Cell Biology on Endemic Diseases, Qinzhou.
Beibu Gulf University · CNQinzhou Maternity and Child Health Care Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dot-blot hybridization and high-resolution melting curve methods are used to detect G6PD gene mutations; however, the performance and throughput limitations of these methods hinder their use for screening large populations. For simple screening, we developed a novel approach called "Amplification Refractory Mutation System combined with Melting Curve Analysis (ARMS-MC)," which enables rapid and batch-based detection of the 6 most common G6PD mutations.In this method, we established 4 PCR reaction systems that can be used to detect the 6 most common G6PD mutations (c.95A>G, c.392G>T, c.871G>A, c.1024C>T, c.1376G>T, and c.1388G>A) in the Chinese population.The ARMS-MC method was evaluated with 174 cases of clinical G6PD-deficient samples, and the results were verified by direct sequencing at G6PD gene exons. The results showed that 170 samples had ≥1 of the 6 mutations, which accounted for 97.70% of all mutations. These results were consistent with the results of direct sequencing with 100% accuracy and specificity. Sequencing validation revealed other mutations in the 4 samples in which no mutation was detected by the ARMS-MC method.ARMS-MC provides a rapid, simple, inexpensive, and accurate screening method for detecting the most common G6PD mutations in Chinese people.

Indexed as

Asian PeopleFemaleGlucosephosphate DehydrogenaseGlucosephosphate Dehydrogenase DeficiencyHumansMalePolymerase Chain ReactionPolymorphism, Single NucleotideGlucosephosphate Dehydrogenase

Identifiers

PMID29702993
PMCPMC5944484
OpenAlexW2979157602

What OpenQuestion holds

Textmetadata
LicenceCC BY-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.